Impact of the Junction Adhesion Molecule-A on Asthma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Junctional adhesion molecule (JAM)-A is an immunoglobulin-like molecule that colocalizes with tight junctions (TJs) in the endothelium and epithelium. It is also found in blood leukocytes and platelets. The biological significance of JAM-A in asthma, as well as its clinical potential as a therapeutic target, are not well understood. The aim of this study was to elucidate the role of JAM-A in a mouse model of asthma, and to determine blood levels of JAM-A in asthmatic patients. Materials and Methods: Mice sensitized and challenged with ovalbumin (OVA) or saline were used to investigate the role of JAM-A in the pathogenesis of bronchial asthma. In addition, JAM-A levels were measured in the plasma of asthmatic patients and healthy controls. The relationships between JAM-A and clinical variables in patients with asthma were also examined. Results: Plasma JAM-A levels were higher in asthma patients (n=19) than in healthy controls (n=12). In asthma patients, the JAM-A levels correlated with forced expiratory volume in 1 second (FEV1%), FEV1/forced vital capacity (FVC), and the blood lymphocyte proportion. JAM-A, phospho-JNK, and phospho-ERK protein expressions in lung tissue were significantly higher in OVA/OVA mice than in control mice. In human bronchial epithelial cells treated with house dust mite extracts for 4 h, 8 h, and 24 h, the JAM A, phospho-JNK, and phospho-ERK expressions were increased, as shown by Western blotting, while the transepithelial electrical resistance was reduced. Conclusion: These results suggest that JAM-A is involved in the pathogenesis of asthma, and may be a marker for asthma.
Abstract
Purpose: Junctional adhesion molecule (JAM)-A is an immunoglobulin-like molecule that colocalizes with tight junctions (TJs) in the endothelium and epithelium. It is also found in blood leukocytes and platelets. The biological significance of JAM-A in asthma, as well as its clinical potential as a therapeutic target, are not well understood. The aim of this study was to elucidate the role of JAM-A in a mouse model of asthma, and to determine blood levels of JAM-A in asthmatic patients. Materials and Methods: Mice sensitized and challenged with ovalbumin (OVA) or saline were used to investigate the role of JAM-A in the pathogenesis of bronchial asthma. In addition, JAM-A levels were measured in the plasma of asthmatic patients and healthy controls. The relationships between JAM-A and clinical variables in patients with asthma were also examined. Results: Plasma JAM-A levels were higher in asthma patients (n=19) than in healthy controls (n=12). In asthma patients, the JAM-A levels correlated with forced expiratory volume in 1 second (FEV1%), FEV1/forced vital capacity (FVC), and the blood lymphocyte proportion. JAM-A, phospho-JNK, and phospho-ERK protein expressions in lung tissue were significantly higher in OVA/OVA mice than in control mice. In human bronchial epithelial cells treated with house dust mite extracts for 4 h, 8 h, and 24 h, the JAM A, phospho-JNK, and phospho-ERK expressions were increased, as shown by Western blotting, while the transepithelial electrical resistance was reduced. Conclusion: These results suggest that JAM-A is involved in the pathogenesis of asthma, and may be a marker for asthma.
참고문헌 (32)
- Amieva MR, "Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA", Science, 300, pp.1430~1434 (2003)
- Martìn-Padura I, "Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration", J Cell Biol, 142, pp.117~127 (1998)
- Ebnet K, "Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1", J Biol Chem, 275, pp.27979~27988 (2000)
- Bazzoni G, "Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin", J Biol Chem, 275, pp.20520~20526 (2000)
- Cunningham SA, "A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions", J Biol Chem, 275, pp.34750~34756 (2000)
- Johnson-Léger CA, "Junctional adhesion molecule-2(JAM-2)promotes lymphocyte transendothelial migration", Blood, 100, pp.2479~2486 (2000)
- Arrate MP, "Cloning of human junctional adhesion molecule 3(JAM3)and its identification as the JAM2 counter-receptor", J Biol Chem, 276, pp.45826~45832 (2001)
- Liang TW, "Vascular endothelial-junctional adhesion molecule(VE-JAM)", JAM 2 interacts with T, NK, and dendritic cells through JAM 3, 2002, pp.168, 1618~1626
- Santoso S, "The junctional adhesion molecule 3(JAM-3)on human platelets is a counterreceptor for the leukocyte integrin Mac-1", J Exp Med, 196, pp.679~691 (2002)
- Hirabayashi S, "JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1", Mol Cell Biol, 23, pp.4267~4282 (2003)
- Kakogiannos N, "JAM-A acts via C", EBP-α to promote claudin-5 expression and enhance endothelial barrier function, 2020, pp.127, 1056~1073
- Denk S, "Early detection of junctional adhesion molecule-1(JAM-1)in the circulation after experimental and clinical polytrauma", Mediators Inflamm, 2015, pp.463950~ (2015)
- Zhang M, "Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression", PLoS One, 8, pp.e79173~ (2013)
- Kaplan A, "GINA 2020 : potential impacts, opportunities, and challenges for primary care", J Allergy Clin Immunol Pract, 9, pp.1516~1519 (2021)
- Mitchell LA, "Junctional adhesion molecule A promotes epithelial tight junction assembly to augment lung barrier function", Am J Pathol, 185, pp.372~386 (2015)
- Thölmann S, "JAM-A interacts with α3β1 integrin and tetraspanins CD151and CD9 to regulate collective cell migration of polarized epithelial cells", Cell Mol Life Sci, 79, pp.88~ (2022)
- Bonilha CS, "Junctional adhesion molecule-A on dendritic cells regulates Th1 differentiation", Immunol Lett, 235, pp.32~40 (2021)
- Brozat JF, "JAM-A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence", Liver Int, 42, pp.1185~1203 (2022)
- Czubak-Prowizor K, "The F11 receptor(F11R)", junctional adhesion molecule-A(JAM-A)(F11R, Mol Cell Biochem, pp.2022, 477[DOI]
- Raghavan S, "SARS-CoV-2 spike protein induces degradation of junctional proteins that maintain endothelial barrier integrity", Front Cardiovasc Med, 8, pp.687783~ (2021)
- Wesslau KP, "P2X7 receptor indirectly regulates the JAM-A protein content via modulation of GSK-3β", Int J Mol Sci, 20, pp.2298~ (2019)
- Magara K, "Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma", Cancer Sci, 108, pp.2306~2314 (2017)
- Wang Y, "MicroRNA-374b inhibits the tumor growth and promotes apoptosis in non-small cell lung cancer tissue through the p38", ERK signaling pathway by targeting JAM-2, 2018, pp.10, 5489~5498
- Lee PH, "Recent patents in allergy and immunology : a quantitative real-time polymerase chain reaction method for diagnosing asthma and asthma exacerbation", Clin Transl Allergy, 12, pp.e12136~ (2022)
- Lee PH, "Nectin4is a potential therapeutic target for asthma", Front Immunol, 13, pp.1049900~ (2022)
- Park S, "Association of the tight junction protein claudin-4 with lung function and exacerbations in chronic obstructive pulmonary disease", Int J Chron Obstruct Pulmon Dis, 16, pp.2735~2740 (2021)
- 김병곤, "Impact of the Endothelial Tight Junction Protein Claudin-5 on Clinical Profiles of Patients With COPD", Allergy, Asthma & Immunology Research, 10(5), pp.533~542 (2018), 대한천식알레르기학회
- Díaz-Coránguez M, "Tight junctions in cell proliferation", Int J Mol Sci, 20, pp.5972~ (2019)
- Lee Pureun-Haneul, "The Impact of Environmental Pollutants on Barrier Dysfunction in Respiratory Disease", Allergy, Asthma & Immunology Research, 13(6), pp.850~862 (2021), 대한천식알레르기학회[DOI]
- Lee YG, "Effects of air pollutants on airway diseases", Int J Environ Res Public Health, 18, pp.9905~ (2021)
- Lee YG, "Titanium dioxide particles modulate epithelial barrier protein, claudin 7 in asthma", Mol Immunol, 132, pp.209~216 (2021)
- 이푸른하늘, "The Impact of Diesel Exhaust Particles on Tight Junctional Proteins on Nose and Lung in a Mouse Model", Allergy, Asthma & Immunology Research, 13(2), pp.350~352 (2021), 대한천식알레르기학회[DOI]